Annual Current Assets
$4.46 M
-$2.92 M-39.62%
December 1, 2023
Summary
- As of February 12, 2025, RNAZ annual total current assets is $4.46 million, with the most recent change of -$2.92 million (-39.62%) on December 1, 2023.
- During the last 3 years, RNAZ annual current assets has risen by +$3.62 million (+436.02%).
- RNAZ annual current assets is now -80.40% below its all-time high of $22.73 million, reached on December 31, 2021.
Performance
RNAZ Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$3.61 M
-$773.80 K-17.64%
September 1, 2024
Summary
- As of February 12, 2025, RNAZ quarterly total current assets is $3.61 million, with the most recent change of -$773.80 thousand (-17.64%) on September 1, 2024.
- Over the past year, RNAZ quarterly current assets has dropped by -$5.76 million (-61.46%).
- RNAZ quarterly current assets is now -85.67% below its all-time high of $25.20 million, reached on September 30, 2021.
Performance
RNAZ Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RNAZ Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.6% | -61.5% |
| 3 y3 years | +436.0% | -85.7% |
| 5 y5 years | +2078.7% | - |
RNAZ Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.4% | at low | -84.1% | at low |
| 5 y | 5-year | -80.4% | +2078.7% | -85.7% | +568.8% |
| alltime | all time | -80.4% | +2078.7% | -85.7% | +568.8% |
TransCode Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.61 M(-17.6%) |
| Jun 2024 | - | $4.39 M(-34.7%) |
| Mar 2024 | - | $6.71 M(+50.7%) |
| Dec 2023 | $714.30 K(+242.4%) | $4.46 M(-52.5%) |
| Sep 2023 | - | $9.37 M(+91.6%) |
| Jun 2023 | - | $4.89 M(+12.6%) |
| Mar 2023 | - | $4.35 M(-41.1%) |
| Dec 2022 | $208.60 K | $7.38 M(-36.2%) |
| Sep 2022 | - | $11.57 M(-16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $13.92 M(-25.3%) |
| Mar 2022 | - | $18.63 M(-18.0%) |
| Dec 2021 | $206.30 K(-8.0%) | $22.73 M(-9.8%) |
| Sep 2021 | - | $25.20 M(+4565.7%) |
| Jun 2021 | - | $540.20 K(-6.5%) |
| Mar 2021 | - | $577.80 K(-30.5%) |
| Dec 2020 | $224.20 K(>+9900.0%) | - |
| Dec 2020 | - | $831.20 K |
| Dec 2019 | $0.00 | - |
FAQ
- What is TransCode Therapeutics annual total current assets?
- What is the all time high annual current assets for TransCode Therapeutics?
- What is TransCode Therapeutics annual current assets year-on-year change?
- What is TransCode Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly current assets year-on-year change?
What is TransCode Therapeutics annual total current assets?
The current annual current assets of RNAZ is $4.46 M
What is the all time high annual current assets for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total current assets is $22.73 M
What is TransCode Therapeutics annual current assets year-on-year change?
Over the past year, RNAZ annual total current assets has changed by -$2.92 M (-39.62%)
What is TransCode Therapeutics quarterly total current assets?
The current quarterly current assets of RNAZ is $3.61 M
What is the all time high quarterly current assets for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total current assets is $25.20 M
What is TransCode Therapeutics quarterly current assets year-on-year change?
Over the past year, RNAZ quarterly total current assets has changed by -$5.76 M (-61.46%)